The Drug-Induced Respiratory Disease Website
XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis
XXIV.c Eosinophilic pneumonia (pulmonary infiltrates and eosinophilia)
XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis
XXIV.d Acute eosinophilic pneumonia (AEP)
XXVIII. Large airway involvement
XXVIII.a Angioedema (may cause UAO, asphyxia and death)
XXIX. Small airway involvement
XXIX.a Bronchospasm - Wheezing - Asthma
II. Myocardial dysfunction - Heart failure
II.d Cardiovascular collapse - Cardiogenic shock - Hypotension
III. Myocardial ischemia - Coronary artery disease
III.c Coronary vasospasm - Vasospastic angina
VI. Cardiomyopathy
VI.a Cardiomyopathy (acute, subacute, chronic)
X. Pulmonary edema
X.b Pulmonary edema, noncardiogenic (NCPE)
XI. Pulmonary vasculopathies
XI.a Pulmonary arterial hypertension
XVI. Hemorrhage - Bleeding - Hematoma(s)
XVI.e Alveolar hemorrhage (AH), diffuse AH (DAH)
XXII. Acute respiratory/cardiorespiratory failure
XXII.b Acute lung injury - ARDS
XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis
XXIV.d Acute eosinophilic pneumonia (AEP)
XXVIII. Large airway involvement
XXVIII.a Angioedema (may cause UAO, asphyxia and death)
XXXVIII. Miscellaneous - Varia
XXXVIII.d Death following exposure or poisoning
I. Cardiac arrhythmia(s)/dysrhythmia(s) (AF, VT, VF, TdP) - QTc prolongation)
I.l Cardiac- cardiorespiratory/pulmonary arrest
X. Pulmonary edema
X.b Pulmonary edema, noncardiogenic (NCPE)
X. Pulmonary edema
X.d Fluid retention
XIII. Thrombosis - Embolism
XIII.f Fat/oil embolism - The FES embolism syndrome
XV. Chest pain
XV.a Chest pain (acute or subacute), lone or prominent
XXII. Acute respiratory/cardiorespiratory failure
XXII.b Acute lung injury - ARDS
XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis
XXIV.j Organizing pneumonia (OP/BOOP) pattern (an area or areas of consolidation on imaging)
XXIX. Small airway involvement
XXIX.a Bronchospasm - Wheezing - Asthma
XXXIII. Histopathology (for pulmonary pathology see in ‘Pneumotox’ (a free companion App)
XXXIII.o Path: Lipid/fat embolism
XXXVI. Autoimmune syndromes - Systemic reactions or conditions
XXXVI.f Anaphylaxis - Anaphylactoid reaction (either of these can be fatal)
XXXVIII. Miscellaneous - Varia
XXXVIII.a Upper airway obstruction other than angioedema or hematoma
XXXVIII. Miscellaneous - Varia
XXXVIII.k Hypersensitivity reaction (may manifest with fever and/or skin, throat or airway involvement)
XXIII. Hemoglobinopathies (acquired, reversible)
XXIII.a Methemoglobinemia
XXVIII. Large airway involvement
XXVIII.g Thermal (burns, frostbite), chemical or caustic injury (face, buccal mucosa, pharynx, upper airway)
XXXVIII. Miscellaneous - Varia
XXXVIII.f Cyanosis, a low SpO2 and normal measured PaO2
XXXVIII. Miscellaneous - Varia
XXXVIII.o Hemolytic anemia
I. Cardiac arrhythmia(s)/dysrhythmia(s) (AF, VT, VF, TdP) - QTc prolongation)
I.a Cardiac arrhythmias or dysrhythmias (AF, VT, VF, TdP)
III. Myocardial ischemia - Coronary artery disease
III.a Coronary artery disease (acute) - Myocardial ischemia/infarction
III. Myocardial ischemia - Coronary artery disease
III.b Coronary artery disease (subacute, chronic)
VI. Cardiomyopathy
VI.a Cardiomyopathy (acute, subacute, chronic)
VI. Cardiomyopathy
VI.b Hypertrophic cardiomyopathy
VII. Cardiotoxicity
VII.a ‘Cardiotoxicity’
X. Pulmonary edema
X.a Pulmonary edema, cardiogenic
XII. Pericardial involvement
XII.b Pericardial effusion (w/wo tamponade)
XIII. Thrombosis - Embolism
XIII.f Fat/oil embolism - The FES embolism syndrome
XVI. Hemorrhage - Bleeding - Hematoma(s)
XVI.e Alveolar hemorrhage (AH), diffuse AH (DAH)
XXII. Acute respiratory/cardiorespiratory failure
XXII.b Acute lung injury - ARDS
XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis
XXIV.y Exogenous lipoid pneumonia (subacute, acute)
XXXVIII. Miscellaneous - Varia
XXXVIII.h Hypoxemia, low oxygen saturation (may occur in isolation)
I. Cardiac arrhythmia(s)/dysrhythmia(s) (AF, VT, VF, TdP) - QTc prolongation)
I.a Cardiac arrhythmias or dysrhythmias (AF, VT, VF, TdP)
VI. Cardiomyopathy
VI.a Cardiomyopathy (acute, subacute, chronic)
VII. Cardiotoxicity
VII.a ‘Cardiotoxicity’
XII. Pericardial involvement
XII.b Pericardial effusion (w/wo tamponade)
XV. Chest pain
XV.a Chest pain (acute or subacute), lone or prominent
XII. Pericardial involvement
XII.g Pleural/pericardial effusion, ANA positive (DI lupus)
XIV. Pleural involvement
XIV.a Pleural effusion (uni or bilateral) (can accompany ILD induced by the drug)
XIV. Pleural involvement
XIV.d Eosinophilic pleural effusion
XIX. Angioedema
XIX.b Visceral angioedema
XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis
XXIV.a Pneumonitis (ILD)
XXIV. Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis
XXIV.c Eosinophilic pneumonia (pulmonary infiltrates and eosinophilia)
XXVIII. Large airway involvement
XXVIII.a Angioedema (may cause UAO, asphyxia and death)
XXVIII. Large airway involvement
XXVIII.i Tongue involvement (edema, glossitis, hematoma)
XXIX. Small airway involvement
XXIX.a Bronchospasm - Wheezing - Asthma
XXIX. Small airway involvement
XXIX.c Severe or catastrophic bronchospasm or asthma attack (can be fatal)
XXIX. Small airway involvement
XXIX.d Cough (lone)
XXX. Imaging features
XXX.c Imaging: Upper/central airway narrowing
XXXI. Eye catchers
XXXI.a Eye-catcher: Tongue edema
XXXV. Disordered breathing during sleep
XXXV.b Disordered breathing pattern - Cheynes-Stokes respiration
XXXV. Disordered breathing during sleep
XXXV.c Obstructive sleep apnea
XXXVI. Autoimmune syndromes - Systemic reactions or conditions
XXXVI.b Lupus - Lupus syndrome
XXXVIII. Miscellaneous - Varia
XXXVIII.b Unilateral/Hemilingual (angio)edema
XXXVIII. Miscellaneous - Varia
XXXVIII.i Cough syncope